Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Andrzej Bozek & Janne Winterstein. (2021) Montelukast’s ability to fight COVID-19 infection. Journal of Asthma 58:10, pages 1348-1349.
Read now
Read now
Hoang Kim Tu Trinh, So-Hee Lee, Thi Bich Tra Cao & Hae-Sim Park. (2019) Asthma pharmacotherapy: an update on leukotriene treatments. Expert Review of Respiratory Medicine 13:12, pages 1169-1178.
Read now
Read now
Alida Benfante, Marco Basile, Salvatore Battaglia, Mario Spatafora & Nicola Scichilone. (2016) Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics. Therapeutics and Clinical Risk Management 12, pages 1553-1562.
Read now
Read now
Abdel Naser Zaid, Murad N Abualhasan, David G Watson, Ayman Mousa, Nadia Ghazal & Rana Bustami. (2015) Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method. Drug Design, Development and Therapy 9, pages 5315-5321.
Read now
Read now
Hiroto Matsuse & Shigeru Kohno. (2014) Leukotriene receptor antagonists pranlukast and montelukast for treating asthma. Expert Opinion on Pharmacotherapy 15:3, pages 353-363.
Read now
Read now
Nicola Scichilone, Salvatore Battaglia, Alida Benfante & Vincenzo Bellia. (2013) Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients. Clinical Interventions in Aging 8, pages 1329-1337.
Read now
Read now
Articles from other publishers (32)
Heung-Woo Park & Sang Heon Cho. (2023) Management of Elderly Asthma: Key Questions and Tentative Answers. Allergy, Asthma & Immunology Research 15:1, pages 8.
Crossref
Crossref
Hiroyuki Nagase & Maho Suzukawa. 2023. Asthma in the 21st Century. Asthma in the 21st Century
217
230
.
Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Lukasik, Florentina Sava, Alba Angelina, Oscar Palomares, Cezmi A. Akdis, Liam O'Mahony, Milos Jesenak, Oliver Pfaar, María José Torres, Marek Sanak, Sven‐Erik Dahlén & Grzegorz Woszczek. (2022) Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19. Allergy 77:8, pages 2337-2354.
Crossref
Crossref
Abeer Thaher Naji AL-Hasnawi. (2021) Evaluation of Sensitivity and Specificity of Interleukins 25 and 33 in Diagnosis of Pediatric Asthma. Journal of Pure and Applied Microbiology 15:2, pages 845-850.
Crossref
Crossref
Jeanne-Marie Perotin. (2021) Asthme du sujet âgé : les spécificités du traitement. La Presse Médicale Formation 2:2, pages 186-190.
Crossref
Crossref
Hassan Motamed, Mohammadreza Maleki Verki, Hassan Barzegari, Siamak Shariat & Saeed Hesam. (2021) Montelukast Efficacy for Improvement of Adult Acute Phase Mild-Moderate Asthma Attack: A Clinical Trial Study. Current Respiratory Medicine Reviews 16:4, pages 246-251.
Crossref
Crossref
Ameneh Norouzi. (2020) Treatment of SARS-CoV-2 (COVID-19) cases by the oral administration of montelukast tablets. Bionatura 5:4, pages 1304-1308.
Crossref
Crossref
Ankeeta Kumari, Mishal Ejaz, Khurram Anis, Sumeet Kumar, Besham Kumar & Sidra Memon. (2020) Role of Montelukast as Monotherapy in Improving Quality of Life of an Asthmatic Patient in Pakistan. Cureus.
Crossref
Crossref
Alan P. Baptist, Wei Hao, Peter X. Song, Laurie Carpenter, Joel Steinberg & Lavoisier J. Cardozo. (2020) A behavioral intervention can decrease asthma exacerbations in older adults. Annals of Allergy, Asthma & Immunology 124:3, pages 248-253.e3.
Crossref
Crossref
Byung-Keun Kim, So-Young Park, Ga-Young Ban, Mi-Ae Kim, Ji-Hyang Lee, Jin An, Ji-Su Shim, Youngsoo Lee, Ha-Kyeong Won, Hwa Young Lee, Kyoung-Hee Sohn, Sung-Yoon Kang, So Young Park, Hyun Lee, Min-Hye Kim, Jae-Woo Kwon, Sun-Young Yoon, Jae-Hyun Lee, Chin Kook Rhee, Ji-Yong Moon, Taehoon Lee, So Ri Kim, Jong Sook Park, Sang-Heon Kim, Heung-Woo Park, Jae Won Jeong, Sang-Hoon Kim, Young-Il Koh, Yeon-Mok Oh, An-Soo Jang, Kwang Ha Yoo & You Sook Cho. (2020) Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma. Allergy, Asthma & Immunology Research 12:6, pages 910.
Crossref
Crossref
Robert C. Waters & Günther Hochhaus. (2019) Characterization of a dextran-budesonide prodrug for inhalation therapy. European Journal of Pharmaceutical Sciences 129, pages 58-67.
Crossref
Crossref
Pinkus Goldberg. 2019. Treatment of Asthma in Older Adults. Treatment of Asthma in Older Adults
53
69
.
Guillermo Sánchez & Diana Buitrago. (2018) Effect of Montelukast 10 mg in Elderly Patients with Mild and Moderate Asthma Compared with Young Adults. Results of a Cohort Study. The Open Respiratory Medicine Journal 12:1, pages 67-74.
Crossref
Crossref
Alan P. Baptist & Paula J. Busse. (2018) Asthma Over the Age of 65: All's Well That Ends Well. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 764-773.
Crossref
Crossref
R. M. Dunn, P. J. Busse & M. E. Wechsler. (2018) Asthma in the elderly and late-onset adult asthma. Allergy 73:2, pages 284-294.
Crossref
Crossref
Michele Columbo. (2017) Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast. Asthma Research and Practice 3:1.
Crossref
Crossref
Charlotte Suppli Ulrik. (2017) Late-Onset Asthma: A Diagnostic and Management Challenge. Drugs & Aging 34:3, pages 157-162.
Crossref
Crossref
Cottini Marcello & Lombardi Carlo. (2016) Asthma phenotypes: the intriguing selective intervention with Montelukast. Asthma Research and Practice 2:1.
Crossref
Crossref
Hoang Kim Tu Trinh, Ga-Young Ban, Ji-Ho Lee & Hae-Sim Park. (2016) Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients. Drugs & Aging 33:10, pages 699-710.
Crossref
Crossref
Shoroq M. Altawalbeh, Carolyn T. Thorpe, Janice C. Zgibor, Sandra Kane‐Gill, Yihuang Kang & Joshua M. Thorpe. (2016) Antileukotriene Agents Versus Long‐Acting Beta‐Agonists in Older Adults with Persistent Asthma: A Comparison of Add‐On Therapies. Journal of the American Geriatrics Society 64:8, pages 1592-1600.
Crossref
Crossref
Shoroq M. Altawalbeh, Joshua M. Thorpe, Carolyn T. Thorpe & Kenneth J. Smith. (2016) Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy. Value in Health 19:5, pages 537-543.
Crossref
Crossref
C. Raherison, A. Bourdin, P. Bonniaud, G. Deslée, G. Garcia, C. Leroyer, C. Taillé, J. De Blic, J.-C. Dubus, I. Tillié-Leblond & P. Chanez. (2016) Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text). Revue des Maladies Respiratoires 33:4, pages 279-325.
Crossref
Crossref
Mi-Yeong KimWoo-Jung SongSang-Heon Cho. (2016) Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies. Asia Pacific Allergy 6:1, pages 3.
Crossref
Crossref
Nicola Scichilone, Maria T Ventura, Matteo Bonini, Fulvio Braido, Caterina Bucca, Marco Caminati, Stefano Del Giacco, Enrico Heffler, Carlo Lombardi, Andrea Matucci, Manlio Milanese, Roberto Paganelli, Giovanni Passalacqua, Vincenzo Patella, Erminia Ridolo, Giovanni Rolla, Oliviero Rossi, Domenico Schiavino, Gianenrico Senna, Gundi Steinhilber, Alessandra Vultaggio & Giorgio Canonica. (2015) Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. Clinical and Molecular Allergy 13:1.
Crossref
Crossref
Elena Jovanovska Janeva, Zlatica Goseva, Angjelko Gjorchev, Angela Debreslioska, Mirko Spiroski, Beti Zafirova & Magdalena Genadieva Dimitrova. (2015) The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1. Open Access Macedonian Journal of Medical Sciences 3:2, pages 268-272.
Crossref
Crossref
Ga-Young BanHae-Sim Park. (2015) Treatment of allergic diseases in elderly. Journal of the Korean Medical Association 58:1, pages 49.
Crossref
Crossref
Woo-Jung SongYoung-Koo Jee. (2015) More Effective Strategies are Needed for Elderly Asthmatics in Real-World Practice. Allergy, Asthma & Immunology Research 7:5, pages 419.
Crossref
Crossref
Abdel Naser Zaid, Ayman Mousa, Nadia Ghazal & Rana Bustami. (2015) Interchangeability and comparative effectiveness between generic and brand montelukast immediate release tablets after a single oral administration in healthy volunteers. Clinical and Translational Allergy 5:1, pages 37.
Crossref
Crossref
Bhupendrasinh F Chauhan & Francine M Ducharme. (2014)
Addition to inhaled corticosteroids of long-acting beta
2
-agonists versus anti-leukotrienes for chronic asthma
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Constanze Fey, Ursula Thyroff‐Friesinger & Spencer Jones. (2014) Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults. Clinical and Translational Allergy 4:1, pages 29.
Crossref
Crossref
A. J. Theron, H. C. Steel, G. R. Tintinger, C. M. Gravett, R. Anderson & C. Feldman. (2014) Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function. Journal of Immunology Research 2014, pages 1-16.
Crossref
Crossref
Bhupendrasinh F Chauhan, Raja Ben Salah & Francine M Ducharme. (2013) Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. Cochrane Database of Systematic Reviews.
Crossref
Crossref